Mallinckrodt’s stock tumbles as short seller Citron claims next victim

Mallinckrodt PLC’s stock takes a dive after short seller Citron Research sent a bearish tweet, saying the stock has potential to fall more than fellow drug maker Valeant Pharmaceuticals International shares, which Citron went after last month.